Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Genital Neoplasms, Male

• 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION)
• High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• Trial of NanoPac Focal Therapy for Prostate Cancer
• Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
• Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors
• Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
• IACS-010759 in Advanced Cancers
• Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
• Neuromuscular Blockade on Shoulder Pain of Elderly
• Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
• Selumetinib and Olaparib in Solid Tumors
• Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
• Neoadjuvant Listeria or Daratumumab in Prostate Cancer
• Lenvatinib and Capecitabine in Patients With Advanced Malignancies
• Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
• Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis
• Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
• Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
• A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
• Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
• Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
• A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
• Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma